• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Economy VP Harris credits nonexistent federal agency with approving mifepristone: watch
Economy

VP Harris credits nonexistent federal agency with approving mifepristone: watch

by April 24, 2023
by April 24, 2023 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

Vice President Kamala Harris mistakenly said last week that a government agency called the ‘Federal Drug Administration’ approved the abortion pill mifepristone 20 years ago.

While the Federal Drug Administration may seem to be the likely breakdown of the acronym for FDA, the correct agency is the Food and Drug Administration (FDA).

Harris sat down for an interview with Noticias Telemundo’s Vanessa Hauc, which aired Friday evening, where the vice president spoke about abortion and the changes taking place in the U.S.

‘Let’s set the scene. Many months ago, the highest court in our land, the United States Supreme Court, took a constitutional right that had been recognized from the people of America – from the women of America – which is the right to make [a] decision about your own body and your own reproductive health,’ Harris said. ‘The government should not be telling that woman what to do with her body. This evokes, in my mind, very fundamental rights, including the right to freedom for each individual about what is in their best interest.’

The vice president then turned her attention to mifepristone, an abortion pill approved by the Food and Drug Administration in 2000.

A case challenging the FDA’s approval of the drug, which was brought on by pro-life doctors and medical groups, challenges not the pill directly but whether the FDA acted appropriately when it approved the drug more than 20 years ago.

‘On the mifepristone issue, it’s politicians finding a court, targeting a specific court that they thought would be helpful to them, to take a medication off the market, which was approved 20 years ago by the Federal Drug Administration,’ Harris said.

She then asked anyone to look into their medical cabinet and look at any drug in there that was prescribed by a doctor.

Harris said any of the drugs prescribed, whether to help with pain or extend a person’s quality of life, was FDA approved.

‘Arguably, what they’re doing with mifepristone could happen to any one of those drugs in your medicine cabinet,’ she said.

On Friday, the same day the interview with Harris aired, the Supreme Court ruled that full access to the abortion pill could continue as the lawsuit works its way through the lower federal courts.

The case reached the Supreme Court after Trump-appointed U.S. District Judge Matthew J. Kacsmaryk issued a ruling that sided with pro-life groups by halting the FDA approval of mifepristone.

Kacsmaryk’s order was partially overturned by the 5th U.S. Circuit of Appears, but the appeals court preserved restrictions that made the drug available only to be dispensed up to seven weeks, not 10, and not by mail.

The Justice Department argued that allowing restrictions on the drug to remain in place would create chaos.

Complicating things, a federal judge in Washington ordered the FDA to preserve access to mifepristone under the current rules in response to a separate lawsuit brought by 17 Democrat-led states and the District of Columbia.

Mifepristone is taken with misoprostol in a two-drug regimen that first blocks hormones needed to keep an unborn baby alive and then causes cramps and contractions to expel the dead fetus from the mother’s womb.

The drug is 97% effective in terminating early pregnancy, though approximately 3% of women who take it will ‘require surgical intervention for ongoing pregnancy, heavy bleeding, incomplete expulsion or other reasons such as patient request,’ according to the manufacturer.

Christ Pandolfo, Adam Sabes, Shannon Bream and Bill Mears of Fox News contributed to this report.

Greg Wehner is a breaking news reporter for Fox News Digital.

This post appeared first on FOX NEWS
You Might Also Like
  • Rep. Massie presses Garland on constitutionality of Special Counsel Jack Smith’s appointment
  • Hamas rejects Israeli two-month cease-fire proposal, prisoner swap over demand for leadership’s end
  • Republicans’ SPR bill leaves Democrats squirming over oil leasing: ‘It’s the process of balance’
  • ND Gov Doug Burgum to participate in GOP presidential debate after suffering leg injury
Share
0
FacebookTwitterPinterestWhatsapp

previous post
Psaki has dessert in ‘hard-hitting interview’ with former boss: ‘Doesn’t ask tough questions either’
next post
Bed Bath & Beyond files for bankruptcy

You may also like

Biden campaign accepts VP debate invitation for summer showdown with...

May 17, 2024

Venezuelan migrant accused of raping woman in front of 3-year-old...

August 9, 2023

White House unveils new AI regulations for federal agencies

March 28, 2024

DeSantis touts his potential to beat Biden if he runs...

March 23, 2023

Top political courtroom moments of 2023

December 22, 2023

Biden admin notes ‘urgent’ concern over Israel in Gaza human...

April 23, 2024

Biden admin appears to give pass to Chinese-backed green energy...

April 22, 2023

Trump reacts to ‘abuse’ by DOJ: ‘This is what you...

July 28, 2023

Exclusive: Hamas, Islamic Jihad accused of using child soldiers in...

January 4, 2024

Connecticut Senate passes bill allowing voters to cast their ballots...

May 31, 2023

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • OpenAI to release web browser in challenge to Google Chrome

      July 10, 2025
    • Sports executive charged with bid-rigging in Texas arena project

      July 10, 2025
    • How I Triple My Returns With 3x Leveraged ETFs!

      July 10, 2025
    • Want Faster, Lower Risk Trades? Use This Setup

      July 9, 2025
    • The Seasonality Trend Driving XLK and XLI to New Highs

      July 9, 2025

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 3,631 views
    • 2

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,919 views
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,607 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,576 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,449 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,169)
    • Investing (538)
    • Stock (2,661)

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 2

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • OpenAI to release web browser in challenge to Google Chrome

      July 10, 2025
    • Sports executive charged with bid-rigging in Texas arena project

      July 10, 2025
    • How I Triple My Returns With 3x Leveraged ETFs!

      July 10, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,169)
    • Investing (538)
    • Stock (2,661)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    Biden to meet with King Charles...

    July 3, 2023

    Bold prediction: What the Senate GOP...

    September 8, 2024

    State AGs warn Biden AI order...

    February 6, 2024
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here